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study question: Are assisted reproductive technology (ART) treatment factors or infertility diagnoses associated with autism among
ART-conceived children?
summaryanswer:Our study suggests that the incidence of autism diagnosis in ART-conceived children during the first 5 years of life was
higherwhen intracytoplasmic sperm injection (ICSI)wasusedcomparedwith conventional IVF, and lowerwhenparentshadunexplained infertility
(among singletons) or tubal factor infertility (among multiples) compared with other types of infertility.
what is known already: Some studies found an increased risk of autismamongART-conceived infants comparedwith spontaneously-
conceived infants. However, few studies, and none in the USA, have examined the associations between types of ART procedures and parental
infertility diagnoses with autism among ART-conceived children.
studydesign, size, duration: Population-based retrospective cohort studyusing linkagesbetweenNationalARTSurveillanceSystem
(NASS) data for 1996–2006, California BirthCertificate data for 1997–2006, andCaliforniaDepartment ofDevelopmental Services (DDS)Autism
Caseload data for 1997–2011.
participants/materials, setting, methods: All live born ART-conceived infants born in California in 1997–2006
(n ¼ 42 383) with 5-year observation period were included in the study. We assessed the annual incidence of autism diagnosis documented in
DDS,which includes informationon thevastmajorityofpersonswith autism inCalifornia, and theassociationof autismdiagnosiswithARTtreatment
factors and infertility diagnoses.
main results and the role of chance: Among ART-conceived singletons born in California between 1997 and 2006, the inci-
dence of autism diagnosis remained at0.8% (P for trend 0.19) andwas lowerwith parental diagnosis of unexplained infertility (adjusted hazard risk
ratio [aHRR]; 95% confidence interval: 0.38; 0.15–0.94) and higher when ICSI was used (aHRR 1.65; 1.08–2.52), when compared with cases
without these patient and treatment characteristics. Among ART-conceived multiples, the incidence of autism diagnosis between 1997 and 2006
remained at 1.2% (P for trend 0.93) and was lower with parental diagnosis of tubal factor infertility (aHRR 0.56; 0.35–0.90) and higher when
ICSI was used (aHRR 1.71; 1.10–2.66).
limitations, reasons for caution: Study limitations include imperfect data linkages, lack of data on embryo quality and possible
underestimation of autism diagnosis cases. Limitations of the observational study design could affect the analysis by the possibility of residual
confounders. Since information about ICSI use was missing for most frozen/thawed embryo transfer cycles, our findings of association of ICSI
use and autism diagnosis can only be generalizable to fresh embryo transfer cycles.
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wider implications of the findings: Our study provides additional evidence of the association between some types of ART pro-
cedureswith autism diagnosis. Additional research is required to explain the increased risk of autismdiagnosiswith ICSI use, aswell as studies on the
effectiveness and safety of ICSI.
study funding/competing interest(s): Thestudywaspartially supportedby theNational Institutes ofHealth. Theauthors have
no competing interests that may be relevant to the study.
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Introduction
Theuseof assisted reproductive technology (ART),which includes all pro-
cedures that involve handling of oocytes and spermor embryos outside of
thehumanbody,hasbeen increasing steadily since itwasfirst introduced in
1978.Over 5million children conceivedwithARThavebeenborn globally
(Adamson et al., 2013). About 1.5%of all infants born in theUSA are con-
ceived using ART (Sunderam et al., 2013). The effect of ART procedures
on the health and development of children has been an area of special
interest for researchers during the last three decades. However, studying
the long-termoutcomesofART isdifficult inpart due to rapid technologic-
al progress in this relatively new field ofmedicine. Remarkable advances in
embryo culture, cryopreservation of embryos and oocytes, ICSI, preim-
plantation genetic testing, and assisted hatching have led to the develop-
ment of new treatment options. The safety—including long-term
safety—of these new treatments requires careful study.
One area of interest is the potential association betweenART fertility
treatments and autism, a serious neurodevelopmental disorder charac-
terized by impairments in social functioning and communication, and
repetitive, stereotyped behaviors, which commonly co-occurs with
intellectual disability (CDC, 2014). The prevalence of identified autism
rapidly increased during the last decade (CDC, 2014). Results of
studies that have compared the risk of autism among ART-conceived
and spontaneously-conceived infants aremixed (Stein et al., 2006;Maim-
burg and Vaeth, 2007; Hvidtjorn et al., 2009, 2011; Zachor and Ben
Itzchak, 2011; Lyall et al., 2012; Conti et al., 2013; Hart and Norman,
2013; Lehti et al., 2013). It is uncertain whether positive associations
are accounted for by the ART procedure itself or underlying character-
istics of ART patients and increased incidence of multiple births after
ART. Few studies, and none in the USA, have examined the associations
between types of ARTprocedures and parental infertility diagnoseswith
autism among ART-conceived children (Hvidtjorn et al., 2011; Bay et al.,
2013; Sandin et al., 2013). A recent study from Sweden found that fresh
embryo transfer ART procedures using ICSI for male factor infertility
were associated with increased risk of autistic disorder and intellectual
disability in offspring compared with fresh embryo transfer procedures
without ICSI (Sandin et al., 2013). However, a study from Denmark
found no effect of ICSI or conventional IVF on neurodevelopment of
children (Bay et al., 2013).
In the USA, the use of ICSI, originally developed for the treatment of
male factor infertility (Palermo et al., 1992), has increased dramatically
during the last decade and is now used in 67% of all ART procedures
regardless of infertility diagnosis (CDC, 2013a). Our study objectives
were to assess whether ART treatment factors or infertility diagnoses
among couples who use ART are associated with autism. Based on the
results from previous studies, we specifically investigated the association
of ICSI use with autism while controlling for other treatment factors.
Methods
Study population and data sources
This population-based retrospective cohort study included all live bornART-
conceived infants born in 1997–2006 in the state of California. The 2006
cutoff was chosen to ensure that each child in the study has fixed 5-year
observation period. The study is based on linkages between National ART
Surveillance System (NASS) data for 1996–2006, California Birth Certificate
data for 1997–2006 and California Department of Developmental Services
(DDS) Autism Caseload data for 1997–2011. NASS data were linked with
California Birth Certificate data using LinkPlus 2.0 linkage software (CDC,
Atlanta,Georgia) (Zhang et al., 2012).Due to the absenceof direct identifiers
inNASS, the probabilistic linkagemethod utilized the following indirect iden-
tifiers: maternal date of birth, infant’s date of birth, plurality, zip code and
gravidity. Uncertain or duplicate matches were reviewed and resolved
manually by using additional variables: infant sex, maternal race and infant
birthweight. Average linkage rate for all years was 90% (ranging from 88 to
93%). Similar linkages of NASS and Birth Certificate data in other states
were conducted as part of States Monitoring ART (SMART) Collaborative;
validation of such linkages showed high sensitivity and specificity (Mneimneh
et al., 2013). California BirthCertificate datawere linkedwithCaliforniaDDS
Autism Caseload data using a combination of deterministic and probabilistic
linkage methods with the following direct and indirect identifiers: child’s
name, date of birth, sex, race/ethnicity and zip code. Uncertain or duplicate
matches were reviewed and resolved manually using additional variables.
Average linkage rate was 86% (ranging from 82 to 89%). Although more
datapointswere available to linkCalifornia BirthCertificatedatawithCalifor-
nia DDS Autism Caseload data, migration in and out of the state during the
time between birth and autism diagnosis (up to 5 years) could result in
lower linkage rates.
Exposure (ART and related variables)
TheNational ART Surveillance System (NASS) is maintained by the Division
ofReproductiveHealth,Centers forDiseaseControl andPrevention (CDC).
Fertility clinics in the USA aremandated to report data on eachART cycle to
the CDC by the Fertility Clinic Success Rates and Certification Act of 1992
(FCSRCA, 1992). NASS covers an estimated 97% of all ART cycles per-
formed in the USA (CDC, 2013a). Data abstracted from medical records
include patients’ demographics, obstetric history, detailed information on
the ART cycle and information on cycle outcome. The latter is obtained by
active follow-up by fertility clinic and includes information about whether
the cycle resulted in pregnancy, pregnancy outcome and information about
each resultant neonate (gestational age, birthweight and sex). The data
from each clinic are validated by the clinics’ medical director prior to submis-
sion. In addition, 7–10% of reporting clinics are randomly selected each
year for validation by the CDC, during which certain data elements reported
by the clinics (including selected data on patient demographics, ART cycle
and cycle outcomes) are compared with information recorded in medical
records and discrepancy rates are calculated. The discrepancy rate for
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pregnancy outcome has consistently been around 1% (CDC, 2013b). In
2011, 451 clinics reported .152 000 ART cycles.
ART is defined as procedures in which oocytes and sperm or embryos are
handled outside the patient’s body, such as in vitro fertilization (IVF). IVF
involves extracting a woman’s eggs, fertilizing the eggs in the laboratory,
and then transferring the resulting embryo(s) into the woman’s uterus. The
embryos can be transferred either immediately following fertilization and
culture (fresh embryo transfer cycles), or frozen and used at a later time
(frozen/thawed embryo transfer cycles). The definition of ART also includes
rareprocedureswhen gametesor zygotes are transferred into fallopian tubes
(gamete intrafallopian transfer [GIFT] and zygote intrafallopian transfer
[ZIFT], respectively). All variables related to current or previousART proce-
dures were extracted from NASS. Infertility diagnoses were not mutually
exclusive and included tubal factor, ovulation disorders, diminished ovarian
reserve, endometriosis, uterine factor, male factor, other causes and unex-
plained causes. Intracytoplasmic sperm injection (ICSI) is a procedure in
which a single sperm is injected into the oocyte. The collection of semen
for ICSI can be done by either surgical extraction (epididymal aspiration
or testicular biopsy) or non-surgical method (ejaculation). Embryo stage
at transfer was calculated by subtracting the oocyte retrieval date from
the embryo transfer date. Typically, embryos transferred on Day 3 corres-
pond to the cleavage stage of development, whereas embryos transferred
on Day 5 correspond to the blastocyst stage. Assisted hatching was defined
as the purposeful disruption of an embryo’s zona pellucida by laser,
mechanical or chemical means in an effort to improve implantation rates
among poor prognosis patients or on embryos noted to have a thick
zona pellucida.
Outcome (autism and related variables)
The administrativeAutismCaseload database ismaintained by theCalifornia
DDS, the agency through which the State of California provides services and
support to individuals with developmental disabilities, and includes informa-
tion on the vast majority of persons with autism in California (Croen et al.,
2002; DDS, 2002; Sunderam et al., 2013). Since inclusion in the database is
basedon the eligibility for services, it includes caseswith a higher level of func-
tional deficit, such as autistic disorder (as opposed to pervasive developmen-
tal disorder not otherwise specified or Asperger’s disorder), within the
commonly accepted category of autism spectrum disorders (ASD).
Autistic disorder is defined by the American Psychiatric Association’s
Diagnostic and Statistical Manual, 4th edition (DSM-IV, 1994, revised in
2000), which provides standards for the diagnosis and classification of ASD
(APA, 2000). The DDS Autism Caseload database includes children diag-
nosed under the DSM-IV code 299.0, which includes autistic disorder (here-
after, autism). All variables related to autism diagnosis were extracted from
DDS Autism Caseload database. The date of autism diagnosis was defined
as the date of enrollment on the DDS Autism Caseload database. Since
the majority of autism cases are typically diagnosed by age 5 (85.3% in our
sample), we allowed 5 years of follow-up for each child in the study.
We used information from the Client Development Evaluation Report
(CDER) database of the DDS to evaluate symptom severity and functioning
at the child’s initial DDS evaluation. The CDER uses three items to measure
communication (word usage, receptive language and expressive language)
and five items to measure social functioning (interaction with peers and non-
peers, friendship formation and maintenance, and participation in social ac-
tivities).We created equally weighted communication and social functioning
indices by summing the scores for each element in a given construct and
dividing by the total numberof elements.The resulting scoreswere then stan-
dardized by age at diagnosis and birth year; communication and social index
scores in the bottom tertile were defined as low functioning. Due to changes
in the evaluation criteria after 2008, we were only able to assess symptom
severity for children born during 1997–2004.
Other variables
Variables extracted from California Birth Certificate include: maternal and
paternal age at birth, maternal education, maternal race and ethnicity,
number of previous births, mode of delivery, infant sex, plurality, gestation
age, infant birthweight, and birth year.
Statistical analysis
All analyses were conducted using SUDAAN software (Version 10.0,
Research Triangle Institute, Research Triangle Park, NC). Since almost half
of ART-conceived infants are born inmultiple gestations, and due to possible
correlation of the outcomes of siblings from the same gestation, we
accounted for cluster effect by specifying delivery as a cluster with one or
more observations (Hibbs et al., 2010).
We first calculated trends of the incidence of autism diagnosis within the
first 5 years of life among ART-conceived singletons and multiples born in
California between 1997 and 2006 and calculated P-values for trend.
We then calculated percent distribution of selected infant, parental, and
treatment characteristics by autism diagnosis. We compared percent distri-
bution of these characteristics between children diagnosed with autism and
those not diagnosed using chi-square test and reported P-values.
We then selected characteristics that were significant at P, 0.05 level for
inclusion inCox proportional hazardsmodels (one for singletons and one for
multiples) to explore the association of autism diagnosis with these charac-
teristics. Male factor infertility and birth year were included in the models
on the basis of a priori decision. Because of collinearity between number of
fetal hearts at 6-week ultrasound and number of embryos transferred, only
the former variable was included in the models. We estimated crude, and
through Cox proportional hazards models, adjusted, hazard risk ratios
(HRR) and 95% confidence intervals (CI); due to a high percentage (97%) of
missing ICSI data for frozen/thawed embryo transfer cycles (represented
15% of all cycles), we used a weight-adjusted approach (SUDAAN’sWTAD-
JUST procedure) to adjust for missing values. We report unadjusted and
adjusted HRRs for our primary exposures of interest, ART treatment factors
and parental infertility diagnoses. Infant and parental characteristics that
were adjusted for included infant sex (male, female), gestational age (≥37
weeks,,37weeks), birthweight (≥2500 g,,2500 g),maternal and paternal
age at delivery (,35 years, 35–39 years, ≥40 years), number of previous
births (0, ≥1), mode of delivery (vaginal, Cesarean), and birth year. For
model checking purposes, we repeated the analysis restricting the sample to
fresh embryo transfer cycles without using weight-adjusted approach, and
restricting multiple births to twin births only.
In additional analysis we built the models (separately for singletons and
multiples) by subsequently adding variables/groups of variables to assess
changes in the HRR for the association between ICSI and autism diagnosis:
Model 1 included infant sex;Model 2 included variables inModel 1, gestation-
al age, birthweight, number of fetal hearts on 6-week ultrasound and birth
year; Model 3 included variables in Model 2, maternal and paternal age at de-
livery, and number of previous births; Model 4 included variables in Model 3
and mode of delivery; Model 5 included variables in Model 4, male factor in-
fertility (yes, no), tubal factor infertility (yes, no), unexplained infertility (yes,
no), source of oocytes (non-donor, donor) and number of fetal hearts on
6-week ultrasound (1, 2, ≥3 for singletons; 2, ≥3 for multiples).
Additionally, we estimated adjusted HRRs and 95% confidence intervals
for the association of autism diagnosis with ICSI stratified by male factor
infertility (yes, no) and method of semen collection (surgical, non-surgical)
among fresh embryo transfer cycles; infants born as a result of conventional
IVF without use of ICSI served as a reference group.
Finally, we assessed autism severity indicators by ICSI use among ART-
conceived children diagnosed with autism. We calculated proportion of
autistic children with low communication index, low social functioning
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index and co-occurring intellectual disability stratified by ICSI use and calcu-
lated risk ratios and 95% CI for the association of autism severity with ICSI.
To protect sensitive information, the study protocol prohibits publication
of small cell tabulations. Therefore, the numbers ,30 are not shown, and
supplementary suppression is performed where appropriate to prevent
back-calculation of small numbers.
This protocol was approved by the Institutional Review Boards at CDC
and Columbia University and the California Committee for the Protection
of Human Subjects.
Results
The annual incidence of autism diagnosis among ART-conceived infants
born between 1997 and 2006 ranged from0.6 to 1.0% among singletons
and from 1.1 to 1.4% among multiples (P for trend 0.19 and 0.93,
respectively) (Fig. 1).
Among 42 383 ART-conceived infants, about half were male, over half
were born in multiple gestations (47% twin and 7% triplet or higher
order gestations), 38% were born preterm and 35% had birthweight
,2500 g (Table I). The majority of mothers of ART-conceived infants
were non-Hispanic white, college graduates, and had Cesarean delivery.
Over 40% of mothers had previous ART procedures and almost 50%
had previous births. Among parents of ART-conceived children, 28% of
mothers and 42% of fathers were 40 years or older at time of delivery.
Male factor infertility was the most common diagnosis of ART patients
(37%), followedbydiminishedovarian reserve (21%) and tubal factor infer-
tility (20%). ICSI was used in 52% of ART procedures; the proportion of
ART cycles with ICSI increased from33% in 1997 to 60% in 2006. Thema-
jority of procedures utilized patient’s own oocytes (79%), freshly fertilized
embryos (85%), cleavage stage embryos (76%) and two ormore embryos
(75%). Extra embryoswere cryopreserved in 52%of fresh embryo transfer
cycles, and assisted hatching was used in 42% of procedures. Among all
ART-conceived infants, 437 (1.0%) were diagnosed with autism within
the first 5 years of life. As comparedwithART-conceived children notdiag-
nosed with autism, a greater percentage of those diagnosed with autism
were male, twins or triplets or higher order multiples, born preterm, and
had low birthweight. Parents of autistic children were older than parents
of children not diagnosedwith autism.Comparedwithmothers of children
without autism, mothers of autistic children were more likely to have no
prior births and have Cesarean delivery, and less likely to have tubal
factor or unexplained infertility. Autism diagnosis among ART-conceived
children was more prevalent with the use of ICSI, donor oocytes and
transfer of .2 embryos.
Among ART-conceived singletons, the incidence of autism diagnosis
was 0.8% (0.7–0.9%) (Table II). Offspring of patients with unexplained
infertility had lower incidence of autism diagnosis than offspring of
patients with other infertility diagnoses (adjusted HRR, 95% CI: 0.38,
0.15–0.94). Use of ICSI was associated with higher incidence of
autism diagnosis (adjusted HRR, 95% CI: 1.65, 1.08–2.52). Among
ART-conceived multiples, the incidence of autism diagnosis was 1.2%
(1.1–1.4%). Offspring of patients with tubal factor infertility had lower
incidence of autism diagnosis than offspring of patients with other infer-
tility diagnoses (adjusted HRR, 95% CI: 0.56, 0.35–0.90). As with
singletons, use of ICSI was associated with higher incidence of autism
diagnosis (adjusted HRR, 95% CI: 1.71, 1.10–2.66). The association
between ICSI and autismdid not substantially changewhenwe restricted
our sample to fresh embryo transfer cycles without using weight-
adjusted approach (adjusted HRR, 95% CI: 1.61, 1.05–2.46 for single-
tons and 1.48, 1.04–2.10 for multiples), or restricted multiple births
to twin births only (adjusted HRR, 95% CI: 1.99, 1.19–3.31).
When variables/groups of variables were added to the model in
sequence, point estimates of the adjusted HRR for the association
between ICSI and autism remained statistically significant, ranging from
1.59 to 1.66 among singletons and from 1.59 to 1.71 among multiples
(Fig. 2).
When the ICSI groupwas stratified bymale factor infertility and semen
collectionmethodamong freshembryo transfer cycles, the associationof
ICSI use with autism diagnosis was attenuated due to reduced sample,
especially when ICSI was used with male factor infertility or surgical
semen collection compared with conventional IVF cycles (adjusted
HRR, 95% CI: 1.23, 0.92–1.64 for ICSI with male factor infertility and
1.22, 0.65–2.31 for ICSI with surgical semen collection) (Fig. 3). The as-
sociation, however, remained significant when ICSI was used without
male factor infertility or non-surgical semen collection (adjusted HRR,
95% CI: 1.57, 1.18–2.09 for ICSI without male factor infertility and
1.41, 1.09–1.81 for ICSI with non-surgical semen collection).
In the analysis of autism severity indicators among a smaller sample of
ART-conceived childrendiagnosedwith autism, no statistically significant
differences were observed by ICSI use status (Table III).
Discussion
Ourstudyusedoneof the largestpopulation-baseddatasetsonARTand is
the first study based in the USA to our knowledge to explore the associ-
ation between ART treatment and parental infertility diagnosis with
autism inART-conceived children.We found that amongART-conceived
children born in California between 1997 and 2006, the incidence of
autism diagnosis remained at 0.8% among singletons and 1.2%
among multiples. Incidence of autism diagnosis was higher when ICSI
was used compared with conventional IVF and lower when parents had
unexplained infertility (among singletons) or tubal factor infertility
(among multiples) compared with other types of infertility.
There has been a significant increase in the reported prevalence of
autism spectrum disorders in California, overall in the USA and in
other countries (Croen et al., 2002; Yeargin-Allsopp et al., 2003;
CDC, 2013c, 2014). During the study period, from 1997 to 2006, the
Figure1 Trends of the incidence of autism diagnosis within the first 5
years of life among assisted reproductive technology-conceived chil-
dren, by plurality, California, 1997–2006.
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Table I Characteristics of assisted reproductive technology (ART)-conceived children and related ART procedures, and













Male 50.8 (21 548) 78.7 (344) 50.6 (21 204)
Female 49.2 (20 835) 21.3 (93) 49.4 (20 742)
Plurality ,0.0001
Singleton 46.7 (19 790) 36.4 (159) 46.8 (19 631)
Twin 46.7 (19 772) 50.3 (220) 46.6 (19 552)
Triplet and higher order multiple 6.7 (2821) 13.3 (58) 6.6 (2763)
Gestational age ,0.0001
≥37 weeks 61.8 (26 176) 48.3 (211) 61.9 (25 965)
,37 weeks 38.2 (16 199) 51.7 (226) 38.1 (15 973)
Birthweight ,0.0001
≥2500 g 65.4 (27 703) 54.2 (237) 65.5 (27 466)
,2500 g 34.6 (14 652) 45.8 (200) 34.5 (14 452)
Number of fetal hearts on 6-week ultrasound ,0.0001
1 fetal heart 43.1 (18 161) 32.3 (139) 43.1 (18 022)
2 fetal hearts 42.1 (17 767) 43.9 (189) 42.1 (17 578)
≥3 fetal hearts 14.8 (6247) 23.4 (101) 14.7 (6146)
Birth year 0.66
1997–1998 11.1 (4702) 11.9 (52) 11.1 (4650)
1999–2000 14.2 (6049) 12.8 (56) 14.3 (5993)
2001–2002 20.9 (8836) 22.4 (98) 20.8 (8738)
2003–2004 26.0 (11 013) 23.6 (103) 26.0 (10 910)
2005–2006 27.8 (11 783) 29.3 (128) 27.8 (11 655)
Parental characteristics
Maternal age at delivery 0.04
,35 years 34.6 (14 657) 32.0 (140) 34.6 (14 517)
35–39 years 37.6 (15 923) 33.9 (148) 37.6 (15 775)
≥40 years 27.8 (11 803) 34.1 (149) 27.8 (11 654)
Maternal race/ethnicity 0.22
Non-Hispanic white 70.3 (29 136) 66.6 (285) 70.4 (28 851)
Non-Hispanic black 2.4 (1001) Not shownb Not shownb
Hispanic 11.1 (4607) Not shownb Not shownb
Asian/Pacific Islander 16.1 (6681) 16.1 (69) 16.1 (6612)
Maternal education 0.06
≤High school graduate 12.0 (4924) 9.3 (39) 12.0 (4885)
Some college 18.1 (7446) 22.1 (93) 18.1 (7353)
College graduate 69.9 (28 778) 68.6 (288) 70.0 (28 490)
Paternal age 0.02
,35 years 24.2 (10 057) 22.0 (94) 24.2 (9963)
35–39 years 33.8 (14 067) 28.7 (123) 33.9 (13 944)
≥40 years 42.0 (17 434) 49.3 (211) 41.9 (17 223)
Continued
























Number of previous ART procedures 0.10
0 43.6 (18 468) 39.6 (173) 43.6 (18 295)
≥1 40.4 (17 129) 44.2 (193) 40.4 (16 936)
Unknown/missing 16.0 (6786) 16.2 (71) 16.0 (6715)
Number of previous births 0.03
0 50.6 (21 442) 55.7 (243) 50.6 (21 199)
≥1 49.4 (20 912) 44.3 (193) 49.4 (20 719)
Mode of delivery ,0.0001
Vaginal delivery 35.9 (15 231) 24.9 (109) 36.1 (15 122)
Cesarean delivery 64.1 (27 152) 75.1 (328) 63.9 (26 824)
Infertility diagnosis and ART treatment characteristics
Infertility diagnosisc
Tubal factor 0.01
Yes 19.6 (8145) 14.8 (63) 19.6 (8082)
No 80.4 (33 517) 85.2 (363) 80.4 (33 154)
Ovulation disorders 0.32
Yes 9.1 (3808) 10.8 (46) 9.1 (3762)
No 90.9 (37 854) 89.2 (380) 90.9 (37 474)
Diminished ovarian reserve 0.09
Yes 20.5 (8559) 24.4 (104) 20.5 (8455)
No 79.5 (33 103) 75.6 (322) 79.5 (32 781)
Endometriosis 0.81
Yes 12.3 (5104) 12.7 (54) 12.2 (5050)
No 87.7 (36 558) 87.3 (372) 87.8 (36 186)
Uterine factor 0.10
Yes 4.8 (2017) 7.0 (30) 4.8 (1987)
No 95.2 (39 645) 93.0 (396) 95.2 (39 249)
Male factor 0.83
Yes 37.0 (15 427) 37.6 (160) 37.0 (15 267)
No 62.4 (26 235) 62.4 (266) 63.0 (25 969)
Other causes 0.70
Yes 15.9 (6625) 16.7 (71) 15.9 (6554)
No 84.1 (35 037) 83.3 (355) 84.1 (34 682)
Unexplained causes ,0.01
Yes 10.9 (4529) 7.0 (30) 10.9 (4499)
No 89.1 (37 133) 93.0 (396) 89.1 (36 737)
Method of embryo fertilization ,0.01
Conventional IVF (without ICSI) 33.0 (13 753) 27.1 (117) 33.1 (13 636)
ICSI 52.2 (21 728) 60.0 (259) 52.1 (21 469)
ICSI unknownd 14.8 (6173) 13.0 (56) 14.8 (6117)
Source of oocytes 0.01
Non-donor (patient’s) oocytes 78.8 (33 399) 72.8 (318) 78.9 (33 081)
Donor oocytes 21.2 (8969) 27.2 (119) 21.1 (8850)
Continued
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incidence of autism diagnosis among ART-conceived children did not
show a similar increase. This may be explained by the positive trend
in ART practice in the USA, where fewer embryos are transferred
during the procedure (Steinberg et al., 2013) and more ART-conceived
infants are born as term singletons with normal birthweight (Joshi et al.,
2012), which have been shown to be inversely associated with autism
diagnosis (Schieve et al., 2011).
The inverse association of unexplained and tubal factor infertility with
autism diagnosis has not been previously described andmight be related
to the characteristics of patients. Patients with unexplained infertility
(14% of all ART cycles performed in the USA in 2011 (CDC, 2013b))
and patients with tubal factor infertility (15% of all ART cycles in 2010
(Kawwass et al., 2013)) tend to be younger. In addition, patients for
whom no cause of infertility was found at the time of ART cycle may
have less severe fertility problems. It is important to note that since
our study was restricted to ART-conceived children, the observed asso-
ciations are not relevant to infertility patients who did not have ART.
The fact that ICSI use was associated with increased incidence of
autism diagnosis after accounting for infant, parental or treatment
factors, suggests that the association cannot be explained by character-
istics known to be associated with ICSI procedures, such as diagnosis of
male factor infertility or older parental age. In fact, the associations with
autism diagnosis were stronger when ICSI was used without male factor
infertility and with non-surgical method of semen collection. ICSI, injec-
tion of a single sperm into an egg, was developed to improve fertilization
in couples with male factor infertility, and is not recommended for
routine use in coupleswith other infertility causes (ASRM, 2012).Never-
theless, the use of ICSI in the USAmore than doubled from 30% in 1996
(CDC, 1998) to 67% in 2011 (CDC, 2013a) in all ART cycles, not only
those for patients with male factor infertility. Interestingly, we did not
observe similar increase in autism diagnosis among ART-conceived
infants during the same time period, which may be explained by the sim-
ultaneous decline of other risk factors shown to be associated with
autism, namely multiple births and low birthweight. Although the exact
mechanism of the association between ICSI and neuro-behavioral disor-
ders, including autism, is yet to be determined, it has been suggested that
epigenetic modifications resulting from either the procedure itself or
characteristics of the patients using the procedure may play a role
(De Rycke et al., 2002; Paoloni-Giacobino and Chaillet, 2004; Dada
et al., 2012). Although several studies reported an association
between oligospermia and abnormal imprinting (Marques et al., 2004,
2008; Dasoula et al., 2007; Kobayashi et al., 2007), our results suggest
thatmale factor infertility may not be themain risk factor for autism diag-
nosis in offspring. The association of ICSI usewith nomale factor infertil-
ity or non-surgical semen collectionwith autismdiagnosis contradicts the
recent study from Swedenwhich showed that fresh embryo transfers in-
volving ICSI with surgically-extracted sperm (indicator of male factor in-
fertility) were associated with autistic disorder, compared with transfers
not involving ICSI (Sandin et al., 2013), and needs to be investigated
further. Possible explanations include the use of ICSI as a rescue tech-
nique when fertilization with conventional IVF fails among patients













Type of embryos used 0.20
Fresh embryos 85.0 (35 996) 87.2 (381) 84.9 (35 615)
Frozen/thawed embryos 15.0 (6372) 12.8 (56) 15.1 (6316)
Days of embryo culture (for fresh ET only)e 0.96
3 days 75.9 (21 796) 77.8 (217) 75.9 (21 579)
5 days 13.4 (3836) 12.5 (35) 13.4 (3801)
Extra embryos cryopreserved (for fresh ET only) 0.69
Yes 52.3 (18 795) 51.2 (195) 52.3 (18 600)
No 47.7 (17 163) 48.8 (186) 47.7 (16 977)
Number of embryos transferred 0.04
≤2 embryos 25.5 (10 816) 20.1 (88) 25.6 (10 728)
3 embryos 31.3 (13 271) 31.8 (139) 31.3 (13 132)
4 embryos 24.0 (10 147) 29.1 (127) 23.9 (10 020)
≥5 embryos 19.2 (8127) 19.0 (83) 19.2 (8044)
Assisted hatching 0.59
Yes 41.8 (17 521) 43.2 (185) 41.8 (17 336)
No 58.2 (24 388) 56.8 (243) 58.2 (24 145)
ET, embryo transfer.
a‘Unknown/missing’ category is shown if .3% of values are unknown or missing; otherwise, these values are excluded from the calculations.
bData not shown due to confidentiality requirements to suppress small cell tabulations; supplementary suppression is performed where appropriate.
cInfertility diagnoses are not mutually exclusive.
dInformation on ICSI use is routinely collected for fresh embryo transfer cycles (,1% missing), but not for frozen/thawed embryo transfer cycles (97% missing).
eLimited to 3 and 5 days of embryo culture.
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Table II Association of autism diagnosis within the first 5 years of life with selected infertility diagnoses and assisted
reproductive technology (ART) treatment characteristics among ART-conceived children, by plurality, California,
1997–2006.







Overall 0.8 (0.7–0.9) – –
Infertility diagnosis
Tubal factor
Yes 0.7 (0.5–1.1) 0.88 (0.58–1.33) 0.89 (0.54–1.48)
No 0.8 (0.7–1.0) Reference Reference
Unexplained causes
Yes 0.4 (0.2–0.8) 0.51 (0.26–1.01) 0.38 (0.15–0.94)
No 0.8 (0.7–1.0) Reference Reference
Male factor
Yes 0.9 (0.7–1.1) 1.11 (0.81–1.52) 0.89 (0.60–1.32)
No 0.8 (0.6–0.9) Reference Reference
Method of embryo fertilization
ICSI 0.9 (0.8–1.1) 1.55 (1.05–2.29) 1.65 (1.08–2.52)
Conventional IVF (without ICSI) 0.6 (0.4–0.8) Reference Reference
Source of oocytes
Donor oocytes 1.0 (0.7–1.4) 1.30 (0.90–1.87) 1.08 (0.68–1.71)
Non-donor (patient’s) oocytes 0.8 (0.6–0.9) Reference Reference
Fetal hearts on 6-week ultrasound
1 fetal heart 0.8 (0.7–0.9) Reference Reference
2 fetal hearts 0.9 (0.5–1.6) 1.20 (0.66–2.15) 1.17 (0.61–2.27)
≥3 fetal hearts 1.6 (0.7–3.8) 2.10 (0.86–5.11) 2.34 (0.91–5.97)
Multiples
Overall 1.2 (1.1–1.4) – –
Infertility diagnosis
Tubal factor
Yes 0.8 (0.6–1.1) 0.61 (0.43–0.87) 0.56 (0.35–0.90)
No 1.3 (1.2–1.5) Reference Reference
Unexplained causes
Yes 0.9 (0.5–1.4) 0.67 (0.41–1.11) 0.62 (0.32–1.23)
No 1.3 (1.1–1.5) Reference Reference
Male factor
Yes 1.2 (1.0–1.5) 0.97 (0.73–1.27) 0.70 (0.44–1.14)
No 1.2 (1.1–1.5) Reference Reference
Method of embryo fertilization
ICSI 1.4 (1.1–1.8) 1.54 (1.09–2.18) 1.71 (1.10–2.66)
Conventional IVF (without ICSI) 0.9 (0.7–1.2) Reference Reference
Source of oocytes
Donor oocytes 1.6 (1.2–2.0) 1.40 (1.04–1.88) 0.85 (0.53–1.36)
Non-donor (patient’s) oocytes 1.1 (1.0–1.3) Reference Reference
Fetal hearts on 6-week ultrasound
2 fetal hearts 1.1 (0.9–1.3) Reference Reference
≥3 fetal hearts 1.6 (1.3–2.1) 1.51 (1.13–2.02) 1.12 (0.80–1.56)
CI, confidence interval.
1Adjusted for infant sex (male, female), gestational age (≥37 weeks, ,37 weeks), birthweight (≥2500 g, ,2500 g), maternal and paternal age at delivery (,35 years, 35–39 years,
≥40 years), number of previous births (0, ≥1), mode of delivery (vaginal, Cesarean), and birth year.
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under-reporting/under-diagnosis of male factor infertility. Our study
provides data on autism severity by ICSI use, although no differences in
the distribution of these factors were statistically significant, possibly
due to small sample size. In our study, co-occurrence of intellectual dis-
ability with autism among ART-conceived children (19.1 and 11.2% for
ICSI and conventional IVF, respectively) is lower than previously
Figure2 Crude and adjusted hazard risk ratios and 95% confidence intervals (CI) for the association of autism diagnosis within the first 5 years of lifewith
ICSI among assisted reproductive technology-conceived singletons (A) and multiple (B), California, 1997–2006. The following adjustments were used:
Model 1: infant sex (male, female); Model 2: variables in Model 1 + gestational age (≥37 weeks, ,37 weeks), birthweight (≥2500 g, ,2500 g),
numberof fetal hearts on 6-weekultrasound (1, 2,≥3 for singletons; 2,≥3 formultiples), birth year;Model 3: variables inModel 2 + maternal and paternal
age at delivery (,35 years, 35–39 years, ≥40 years), number of previous births (0, ≥1); Model 4: variables in Model 3 + mode of delivery (vaginal, Ce-
sarean); Model 5: variables in Model 4 + male factor infertility (yes, no), tubal factor infertility (yes, no), unexplained infertility (yes, no), source of oocytes
(non-donor, donor). Reference group: infants born after conventional IVF (without ICSI).
Figure3 Adjustedhazard risk ratios and 95%confidence intervals (CI) for the associationof autismdiagnosiswithin thefirst 5 yearsof lifewith ICSI among
assisted reproductive technology-conceived children, by male factor infertility and method of semen collection, fresh embryo transfer cycles, California,
1997–2006. The following adjustments were used: infant sex (male, female), gestational age (≥37 weeks, ,37 weeks), birthweight (≥2500 g,
,2500 g), maternal and paternal age at delivery (,35 years, 35–39 years, ≥40 years), number of previous births (0, ≥1), mode of delivery (vaginal, Ce-
sarean), birth year, tubal factor infertility (yes, no), unexplained infertility (yes, no), sourceofoocytes (non-donor, donor), fetal hearts on6-weekultrasound
(1, 2, ≥3), and plurality (singleton, multiple). Reference group: infants born after conventional IVF (without ICSI).
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reported among all children with autism (regardless of conception
method), although there is wide variability by state (CDC, 2014). It
has been reported that prevalence of intellectual disability in autistic chil-
dren is lower when they come from households with higher income
(Rivard et al., 2014), which is the case for ART-conceived children in
the USA.
The results of the study should be considered in light of several limita-
tions. Linkages between National ART Surveillance System data, Birth
Certificate data and Autism Caseload data are imperfect, although ac-
ceptable for surveillance purposes (90% linkage rates). Unlinked
records likely result fromART procedures conducted out of state ormi-
gration to California after birth of a child in another state. According to
the American Community Survey, 7% of children under the age of 5
years living in California in 2005–2007 were born outside of the state
of residence (Census, 2005–2007).Another limitation is thatenrollment
in theCaliforniaDepartment ofDevelopmental Services is voluntary and
may not represent all children diagnosed with autism in the state. Some
cases of autism may be either undiagnosed or underrepresented due to
limited access to the DDS system, which may underestimate the inci-
dence of autism. Although we lacked the data on embryo quality, we
used cryopreservation of extra embryos, which has been demonstrated
to be a good predictor of embryo quality (Stern et al., 2012). Since we
used multiple possible predictors of autism diagnosis and a number of
models, some of our results can be due to chance alone. Limitations of
theobservational studydesign could affect our analysis: althoughwecon-
trolled for several important patient and treatment characteristics, we
cannot exclude the possibility of residual confounders. It is also import-
ant to note that information about ICSI usewasmissing formost frozen/
thawed embryo transfer cycles, and therefore our findings of association
of ICSI use and autism diagnosis can only be generalizable to fresh
embryo transfer cycles.
One of the study strengths includes large sample size with detailed in-
formation onART cycle allowing adjustment for important confounders.
Restriction to ART population minimized the effect of the underlying
causes of infertility and access to treatment on the outcome of interest,
which is a common limitation of studies comparing ART and non-ART
populations. In addition, our study contributes to the literature by inves-
tigating the population of ART-conceived children in the USA, whose
circumstances of conception are different from previously studied popu-
lations of ART-conceived children outside of the USA, primarily in Scan-
dinavia. For example, the use of blastocyst transfer, assisted hatching,
ICSI and transfer of .1 embryo is generally higher in the USA than in
Europe (Chambers et al., 2009; Baker et al., 2010; Sullivan et al., 2013).
Our study provides additional evidence of the association between
some types of ART procedures with autism diagnosis among ART-
conceived children. Additional research is required to explain the
increased risk of autism diagnosis with ICSI use. Given the widespread
use of ICSI in the USA and lack of convincing evidence of its effectiveness
among patients without male factor infertility (ASRM, 2012), more
studies on the effectiveness and safety of ICSI, as well as dissemination
of existing evidence among ART providers are needed. Our study
shows that linking national ART surveillance data with state-based
outcome data, such as the one with Autism Caseload data, is a feasible
and efficient way to study long-term outcomes of ART.
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